Work Interventions to Improve Employment Outcomes for Persons With Rheumatoid Arthritis and Osteoarthritis

This study has been completed.
Sponsor:
Collaborator:
U.S. Department of Education
Information provided by:
University of Missouri-Columbia
ClinicalTrials.gov Identifier:
NCT00485914
First received: June 11, 2007
Last updated: January 27, 2010
Last verified: January 2010
  Purpose

To determine if worksite based functional evaluation/intervention provided by occupational therapists improves employment outcomes for persons with arthritis.


Condition Intervention
Osteoarthritis
Rheumatoid Arthritis
Behavioral: worksite intervention

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Worksite Vocational Rehabilitation Intervention to Improve Employment Outcomes for Persons With Arthritis?

Resource links provided by NLM:


Further study details as provided by University of Missouri-Columbia:

Primary Outcome Measures:
  • Arthritis Impact Measurement Scale-2, Brief Symptom Inventory, Job Satisfaction Survey, Occupational Data information, Work History, Employment Status, Financial Information [ Time Frame: Scores at baseline, 3, 6, 12, 24 months ] [ Designated as safety issue: No ]

Enrollment: 89
Study Start Date: October 2003
Study Completion Date: September 2009
Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: worksite intervention
    Researchers will measure the effects of worksite assessment through educational materials or an on-site work evaluation by an occupational therapist on a person's job satisfaction, capacity to perform work duties, income, health status, and psychological well-being. The two groups involved in the research will either receive educational information or on-site work visits. The scope of the information will either be through educational materials to develop strategies to compensate or one-to-one contact and an individualized work plan. The strategies will include recommendations for work behaviors, ergonomic and body mechanics considerations, and modifications for job tasks, equipment, and space.
Detailed Description:

Arthritis is second only to heart disease as a cause of work-related disability with significant financial costs associated with the loss of work for persons with arthritis. Many persons with arthritis have physical impairments which affect their ability to work, with 50% of persons with rheumatoid arthritis leaving employment within 10 years of diagnosis. Risk factors predicting employability, length of employment and worksite accommodations for workers with arthritis have been well documented. Variables predicting work cessation include blue collar jobs and more physically demanding jobs, an older age of the worker, lower education, perceived job strain, social support of co-workers and supervisors, job satisfaction, and self-efficacy. Recent studies of self-report by persons with arthritis identified the use of worksite accommodations such as others providing assistance at work, job autonomy, time flexibility, and use of special equipment. Unknown is the effect of on-site work interventions. The need exists to determine if the provision of strategies for physical accommodations, worksite modifications, and assistive technologies at the individual's job site improves the ability of persons with arthritis to continue working.

This is a randomized clinical trial to investigate the efficacy of a worksite based intervention to improve the employment outcomes of persons with rheumatoid (RA) or osteoarthritis (OA). Persons with RA or OA who have arthritis related work difficulties will have an occupational therapist provide a worksite evaluation and subsequent training in strategies to accommodate arthritis related physical impairments and improve job performance and satisfaction. Participants in control group will be provided with educational printed materials related for a self-initiated worksite evaluation of musculoskeletal and environmental risks at the worksite for persons with arthritis.

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Rheumatoid arthritis or osteoarthritis diagnosed by a rheumatologist
  • Competitively employed; full or part time
  • Reporting arthritis-related employment difficulties
  • Agree to participate in a work site evaluation

Exclusion Criteria:

  • Systemic complications of RA (e.g., vasculitis)
  • Organic Brain Syndrome
  • Uncontrolled psychiatric disorders
  • Uncontrolled medical conditions (e.g., active cancer)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00485914

Locations
United States, Missouri
University of Missouri-Columbia
Columbia, Missouri, United States, 65212
Sponsors and Collaborators
University of Missouri-Columbia
U.S. Department of Education
Investigators
Principal Investigator: George Johnstone, PhD University of Missouri-Columbia
  More Information

Additional Information:
No publications provided

Responsible Party: George "Brick" Johnstone, University of Missouri-Columbia
ClinicalTrials.gov Identifier: NCT00485914     History of Changes
Other Study ID Numbers: H133B031120-Project 3
Study First Received: June 11, 2007
Last Updated: January 27, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by University of Missouri-Columbia:
employment
work

Additional relevant MeSH terms:
Arthritis
Arthritis, Rheumatoid
Osteoarthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases

ClinicalTrials.gov processed this record on September 16, 2014